Skip to main content
Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Mar 5, 2026, 4:00 PM EST

Statera Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2021 FY 2020 FY 2019 FY 2018
Period Ending
 Sep '22 Dec '21 Dec '20 Dec '19 Dec '18
Other Revenue
1.491.49---
Revenue
3.691.49---
Cost of Revenue
1.10.49---
Gross Profit
2.591---
Selling, General & Admin
12.5719.114.942.235.37
Research & Development
9.8111.835.260.592.14
Operating Expenses
23.7332.2410.237.92
Operating Income
-21.14-31.24-10.2-3-7.92
Interest Expense
-1.69-1.29-0.13-0.12-0.06
Other Non Operating Income (Expenses)
-1.280.15-1--0.34
EBT Excluding Unusual Items
-24.11-32.38-11.33-3.13-8.32
Merger & Restructuring Charges
-0.8-0.8-0.3--
Impairment of Goodwill
-67.71-67.71---
Asset Writedown
0.10.1---
Legal Settlements
-0.03-2.13---
Other Unusual Items
0.731.03-0.46-0.12.19
Pretax Income
-91.86-101.88-12.09-3.22-6.13
Earnings From Continuing Operations
-91.86-101.88-12.09-3.22-6.13
Earnings From Discontinued Operations
-0---
Net Income to Company
-91.86-101.88-12.09-3.22-6.13
Minority Interest in Earnings
0.020.02---
Net Income
-91.83-101.85-12.09-3.22-6.13
Net Income to Common
-91.83-101.85-12.09-3.22-6.13
Shares Outstanding (Basic)
483572017
Shares Outstanding (Diluted)
483572017
Shares Change (YoY)
103.71%381.26%-62.79%14.67%-
EPS (Basic)
-1.91-2.90-1.66-0.16-0.36
EPS (Diluted)
-1.91-2.90-1.66-0.16-0.36
Free Cash Flow
-12.19-28.38-5.09-0.24-4.27
Free Cash Flow Per Share
-0.25-0.81-0.70-0.01-0.25
Gross Margin
70.27%67.16%---
Operating Margin
-573.26%-2100.68%---
Profit Margin
-2490.27%-6849.25%---
Free Cash Flow Margin
-330.68%-1908.24%---
EBITDA
-20.58-30.98-10.2--
D&A For EBITDA
0.560.260--
EBIT
-21.14-31.24-10.2-3-7.92
Source: S&P Capital IQ. Standard template. Financial Sources.